Your search returned 13 results.

Results
	1.	[Temporomandibular joint, occlusion and bruxism]. [electronic resource] by Orthlieb, J D Ré, J P Jeany, M Giraudeau, A Producer: 20170421 In: Revue de stomatologie, de chirurgie maxillo-faciale et de chirurgie orale vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent. [electronic resource] by Rademaker-Lakhai, Jeany M van den Bongard, Desiree Pluim, Dick Beijnen, Jos H Schellens, Jan H M Producer: 20041227 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients. [electronic resource] by Campone, Mario Rademaker-Lakhai, Jeany M Bennouna, Jaafar Howell, Stephen B Nowotnik, David P Beijnen, Jos H Schellens, Jan H M Producer: 20070919 In: Cancer chemotherapy and pharmacology vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer. [electronic resource] by Rademaker-Lakhai, Jeany M Crul, Mirjam Pluim, Dick Sparidans, Rolf W Baas, Paul Beijnen, Jos H van Zandwijk, Nico Schellens, Jan H M Producer: 20051216 In: Anti-cancer drugs vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Relationship between cisplatin administration and the development of ototoxicity. [electronic resource] by Rademaker-Lakhai, Jeany M Crul, Mirjam Zuur, Lot Baas, Paul Beijnen, Jos H Simis, Yvonne J W van Zandwijk, Nico Schellens, Jan H M Producer: 20060314 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancer. [electronic resource] by Beumer, Jan H Rademaker-Lakhai, Jeany M Rosing, Hilde Hillebrand, Michel J X Bosch, Tessa M Lopez-Lazaro, Luis Schellens, Jan H M Beijnen, Jos H Producer: 20070515 In: Cancer chemotherapy and pharmacology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors. [electronic resource] by Rademaker-Lakhai, Jeany M Terret, Catherine Howell, Stephen B Baud, Christiane M De Boer, Richard F Pluim, Dick Beijnen, Jos H Schellens, Jan H M Droz, Jean-Pierre Producer: 20041210 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. [electronic resource] by Allen, John D van Loevezijn, Arnold Lakhai, Jeany M van der Valk, Martin van Tellingen, Olaf Reid, Glen Schellens, Jan H M Koomen, Gerrit-Jan Schinkel, Alfred H Producer: 20030429 In: Molecular cancer therapeutics vol. 1 Availability: No items available. Save to lists Add to cart (remove)
	9.	The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer. [electronic resource] by Claessens, Anouk K M Timman, Reinier Busschbach, Jan J Bouma, Jeanette M Rademaker-Lakhai, Jeany M Erdkamp, Frans L G Tjan-Heijnen, Vivianne C G Bos, Monique E M M Producer: 20200928 In: Breast cancer research and treatment vol. 179 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer. [electronic resource] by Rademaker-Lakhai, Jeany M Horenblas, Simon Meinhardt, Willem Stokvis, Ellen de Reijke, Theo M Jimeno, José M Lopez-Lazaro, Luis Lopez Martin, José A Beijnen, Jos H Schellens, Jan H M Producer: 20050620 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer. [electronic resource] by Claessens, Anouk K M Erdkamp, Frans L G Lopez-Yurda, Marta Bouma, Jeanette M Rademaker-Lakhai, Jeany M Honkoop, Aafke H de Graaf, Hiltje Tjan-Heijnen, Vivianne C G Bos, Monique E M M Producer: 20201217 In: Acta oncologica (Stockholm, Sweden) vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancer. [electronic resource] by Rademaker-Lakhai, Jeany M Beerepoot, Laurens V Mehra, Niven Radema, Sandra A van Maanen, Rianne Vermaat, Joost S Witteveen, Els O Visseren-Grul, Carla M Musib, Luna Enas, Nathan van Hal, Gertjan Beijnen, Jos H Schellens, Jan H M Voest, Emile E Producer: 20071026 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG). [electronic resource] by Claessens, Anouk K M Bos, Monique E M M Lopez-Yurda, Marta Bouma, Jeanette M Rademaker-Lakhai, Jeany M Honkoop, Aafke H de Graaf, Hiltje van Druten, Edith van Warmerdam, Laurence J C van der Sangen, Maurice J C Tjan-Heijnen, Vivianne C G Erdkamp, Frans L G Producer: 20190108 In: Breast cancer research and treatment vol. 172 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)